Debashis Sarker

King's College Hospital — United Kingdom

Medicine · Health Sciences

35h-index7.9kcitations338works1.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatocellular Carcinoma Treatment and Prognosis(64), Pancreatic and Hepatic Oncology Research(51), PI3K/AKT/mTOR signaling in cancer(44), Cancer Immunotherapy and Biomarkers(37), Colorectal Cancer Treatments and Studies(35)

Publications337 total

Selective internal radiation therapy (SIRT) for stage IV adrenal cortical cancer: a case report and review of the literature
Endocrine Abstracts·2026
Multimodal treatment and tumour biology‑driven long‑term survival in PSC‑associated hilar cholangiocarcinoma: A case report
Medicine International·2026Open Access
Supplementary Methods. MS1 from A Phase I/II Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination with Low-Dose Gemcitabine in Patients with Advanced Cancer
2025Open Access
Demographic and Disease Characteristics from A Phase I/II Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination with Low-Dose Gemcitabine in Patients with Advanced Cancer
2025Open Access
Mean plasma SRA737 concentration over time from A Phase I/II Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination with Low-Dose Gemcitabine in Patients with Advanced Cancer
2025Open Access
Mean exposure (AUC0–12) by dose level from A Phase I/II Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination with Low-Dose Gemcitabine in Patients with Advanced Cancer
2025Open Access
Real world outcomes for patients with high grade neuroendocrine neoplasms at Guy's Cancer Centre
Endocrine Abstracts·2025
Experimental Cancer Medicine Centre (ECMC) network proposal for a consensus gene panel for pan-cancer sequencing: a Delphi methodology
British Journal of Cancer·2025Open Access
609 Restoring immune responsiveness in periphery and tumor with mRNA-4359, an mRNA-based therapy encoding PD-L1 and IDO1 peptides, plus pembrolizumab in checkpoint inhibitor resistant/refractory melanoma
Regular and Young Investigator Award Abstracts·2025Open Access
841P Phase I/II dose-escalation study evaluating ginisortamab (UCB6114), an anti-gremlin-1 monoclonal antibody (mAb) with first-in-class potential, in combination with 5-fluorouracil, leucovorin and oxaliplatin (mFOLFOX6) in advanced solid tumours
Annals of Oncology·2025
838P Phase I/II dose-escalation study evaluating ginisortamab (UCB6114), an anti-gremlin-1 monoclonal antibody (mAb) with first-in-class potential, in combination with trifluridine/tipiracil (TFD/TPI) in advanced solid tumours
Annals of Oncology·2025
1515MO Clinical outcomes and PD-L1 expression analyses from a trial of mRNA-4359 plus pembrolizumab in checkpoint inhibitor-resistant/refractory (CPI-R/R) melanoma
Annals of Oncology·2025· 1 cited
Phase I trial of ADP-A2AFP TCR T-cell therapy in patients with advanced hepatocellular or gastric hepatoid carcinoma
Journal of Hepatology·2025· 5 citedOpen Access
Dendrimer-Nanoparticle (DEP) Delivery of Topoisomerase I Inhibitor, SN38 (DEP-SN38): Safety, Tolerability, and Preliminary Efficacy Study in Patients With Advanced Solid Tumors
Journal of Clinical Oncology·2025· 1 cited
Prognosis of NETs has there been improvement over the last 30 years
Neuroendocrinology·2025· 1 citedOpen Access
Guy’s Cancer Cohort: Guy’s Cancer Centre’s Real-World Evidence Programme 5 years later
ESMO Real World Data and Digital Oncology·2025Open Access
SAT-086 Tumour-infiltrating regulatory T cells engage Nrf2 signalling to support their metabolic adaptation in hepatocellular carcinoma
Journal of Hepatology·2025
Abstract CT156: Phase 1 dose-optimization study evaluating the safety of ginisortamab (UCB6114), an anti-gremlin-1 monoclonal antibody (mAb) with first-in-class potential, as monotherapy in advanced solid tumors
Cancer Research·2025
TIMEPOINT, a phase 1 study combining MTL-CEBPA with pembrolizumab, supports the immunomodulatory effect of MTL-CEBPA in solid tumors
Cell Reports Medicine·2025· 9 citedOpen Access
Computed Tomography Fistulography in the Diagnosis of Thyroglossal Fistula: A Case Report
Bangladesh Journal of Otorhinolaryngology·2024Open Access
page 1 of 17Next →

Frequent Co-authors

Daniel H. Palmer(7), Johann S. de Bono(7), Tim Meyer(7), Rebecca Kristeleit(6), Udai Banerji(6), Andrew X. Zhu(5), Julien Edeline(5), Stephen L. Chan(5), Ruth Plummer(5), Richard S. Finn(4), Stéphane Cattan(4), Sadahisa Ogasawara(4), Chris Verslype(4), Vittorina Zagonel(4), Gontran Verset(4), Jennifer J. Knox(4), Bruno Daniele(4), Abby B. Siegel(4), Ann‐Lii Cheng(4), Masatoshi Kudo(4)